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Abstract
Background: To facilitate the screening of large quantities of new antimicrobial peptides (AMPs), we describe a
cost-effective method for high throughput prokaryotic expression of AMPs. EDDIE, an autoproteolytic mutant of
the N-terminal autoprotease, Npro, from classical swine fever virus, was selected as a fusion protein partner. The
expression system was used for high-level expression of six antimicrobial peptides with different sizes: Bombinin-
like peptide 7, Temporin G, hexapeptide, Combi-1, human Histatin 9, and human Histatin 6. These expressed AMPs
were purified and evaluated for antimicrobial activity.
Results: Two or four primers were used to synthesize each AMP gene in a single step PCR. Each synthetic gene
was then cloned into the pET30a/His-EDDIE-GFP vector via an in vivo recombination strategy. Each AMP was then
expressed as an Npro fusion protein in Escherichia coli. The expressed fusion proteins existed as inclusion bodies in
the cytoplasm and the expression levels of the six AMPs reached up to 40% of the total cell protein content. On in
vitro refolding, the fusion AMPs was released from the C-terminal end of the autoprotease by self-cleavage, leaving
AMPs with an authentic N terminus. The released fusion partner was easily purified by Ni-NTA chromatography. All
recombinant AMPs displayed expected antimicrobial activity against E. coli, Micrococcus luteus and S. cerevisia.
Conclusions: The method described in this report allows the fast synthesis of genes that are optimized for over-
expression in E. coli and for the production of sufficiently large amounts of peptides for functional and structural
characterization. The Npro partner system, without the need for chemical or enzymatic removal of the fusion tag, is
a low-cost, efficient way of producing AMPs for characterization. The cloning method, combined with bioinformatic
analyses from genome and EST sequence data, will also be useful for screening new AMPs. Plasmid pET30a/
His-EDDIE-GFP also provides green/white colony selection for high-throughput recombinant AMP cloning.
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Background
Antimicrobial peptides are widely distributed in nature
and play a critical role in the innate immunity of host
defense systems. They act with broad spectrum and,
hence, are promising candidates for therapeutic and
industrial application [1-5]. For research studies and
clinical trials, large quantities of these peptides are
needed [6]. The number of described AMPs has
increased over recent decades [7]; however, the recent
generation of huge amounts of genomic, proteomic and
EST (Expressed Sequence Tag) data enables novel stra-
tegies for the discovery of new candidate AMPs [8-10].
In silico methods based on bioinformatic analyses, com-
bined with experimental screening techniques have been
developed to screen and identify new AMP genes from
huge “-omics” data sets [11,12]. Belarmino et al.
screened 237,954 ESTs of sugarcane using a computa-
tional approach and successfully identified 17 new
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however, there is a requirement for a high throughput
genome-scale DNA cloning and expression system to
enable the antimicrobial activities of putative AMPs to
be characterized [9,14,15].
Expression of fusion proteins that form inclusion
bodies has several advantages that can overcome major
barriers of AMP expression in E. coli:h i g hr a t e so f
expression, easy collection by centrifugation, protection
from proteolysis and the avoidance of intrinsic AMP
antimicrobial activity against host cells [16,17]. However,
recombinant AMPs expressed in E. coli often include
1-2 non-native amino acid residuals at the N terminus
of the target protein due to a specific linker sequence
recognized by endoproteases or chemical agents, typi-
cally located between the native protein sequence and
the tag [18]. These non-authentic N termini of AMPs
often alter their characteristics. It is, therefore, very
important to develop a new strategy for authentic
recombinant AMP expression. The N-terminal autopro-
tease, Npro, of classical swine fever virus (CSFV) cleaves
itself between the C-terminal Cys168 and position 169
[19], which represent the authentic N-terminal amino
acid of the target protein. It is also a relatively hydro-
phobic protein that tends to form insoluble aggregates
on refolding, preventing autoproteolysis [20]. In this
approach, the target protein is fused to the C-terminus
of Npro and is expressed in inclusion bodies. After
inclusion bodies are isolated, an in vitro refolding step is
necessary to induce autoproteolysis, and render the
AMPs biologically active [21]. Importantly, cleavage
does not need to be initiated by the use of reducing
agents or by temperature and pH shifts. EDDIE, a
mutant of Npro, shows improved solubility and faster
refolding and cleavage than wild-type Npro [16]. In our
previous work, the fusion protein EDDIE-CAD was suc-
cessfully expressed in E. coli after codon optimization
and the purified recombinant mature Cecropin AD
(CAD) was fully bioactive [22].
The in vitro cloning of DNA molecules traditionally
uses PCR or site-specific restriction endonucleases to
generate linear DNA inserts with defined termini and
requires DNA ligase to covalently join these inserts to
vectors with the corresponding ends [23]. However,
restriction endonuclease sites often introduce a few
amino acids to the N-terminus of mature peptides, and it
is very difficult to analyze recombinant clones when the
insert DNA fragment is very short. For high throughput
subcloning of short peptide genes, we constructed the
vector, pET30a/His-EDDIE-GFP (Figure 1A), and used a
Figure 1 Schematic representation of the Construction of (A) pET30a/His-EDDIE-GFP and (B) pET30a/His-EDDIE-AMPs vectors. (A)
pET30a/His-EDDIE-CAD was used to constructed pET30a/His-EDDIE-GFP. This plasmid was derived from pET30a and uses a T7-inducible promoter
with lac operator, contains the low-copy pBR322 origin of replication, and encodes the kanamycin resistance gene (kanR) and the lac repressor
gene (lacI). The GFP gene was inserted at the Sal I site and replaced CAD gene of pET30a/His-EDDIE-CAD, which at downstream positions of the
EDDIE gene, give rise to the vector pET30a/His-EDDIE-GFP for expression of AMPs in E. coli. (B) The AMPs genes were inserted downstream of
the carrier protein using overlap primer (arrows) at 168 site. The separate of AMPs and carrier partner between self-cleavage sites while in vitro
refolding is shown in the square box, while the self-cleavage site is indicated by an arrow.
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expression of AMPs in E. coli, This method allows one-
step assembly of DNA fragments in vivo via homologous
recombination in E. coli [24]. For high level expression,
codon usages of synthesized AMP genes were optimized
according to the host strains. For efficient analysis of
short insert DNA fragments, the recombinants were
easily screened by GFP green/white colony selection. In
this article, our approach was validated using 6 target
AMPs of variable length.
Results
Construction of his-EDDIE-GFP fusion expression plasmid
The construction of the pET30a/His-EDDIE-GFP vector
was based on pET30a/His-E D D I E - C A D .A f t e rP C R
amplification, the GFP fragment was successfully sub-
cloned into pET30a/His-EDDIE-CAD. Colonies showing
green fluorescence were picked and PCR amplification
of the GFP gene followed by gel electrophoresis showed
that the GFP fragment had been successfully inserted
into the expression vector (Figure 2A, B). DNA sequen-
cing validated that the GFP gene was inserted down-
stream of the EDDIE gene.
Construction of the his-EDDIE-AMP fusion expression
plasmid
To clone AMP genes in a high-throughput manner, we
performed a green/white colony screen using the GFP
in pET30a/His-EDDIE-GFP. After a target gene is
cloned into the vector by a one-step PCR technique, the
GFP gene is destroyed; therefore, green fluorescence
indicates non-linearized parental vector. Four AMP
genes, Temporin G, hexapeptide, Combi-1 and Histatin
9 were amplified and cloned downstream of EDDIE
using a one-step PCR process, and then transformed
into E. coli cells (Figure 3A). BLP-7 and Histatin 6
genes were assembled using four primers in one PCR
reaction, respectively (Figure 3B). pET30a/His-EDDIE-
GFP was replicated at the same time. The two PCR pro-
ducts were then transformed into E. coli cells together.
The transformants were screened under ultraviolet light,
and the white colonies were further screened by PCR
verification and sequencing. The recombinant pET30a/
His-EDDIE-AMP plasmid is smaller than the parental
pET30a/His-EDDIE-GFP plasmid, which makes it very
easy to distinguish the two plasmids by agarose gel elec-
trophoresis (Figure 3C).
Expression and purification of fusion proteins
E. coli BL21 (DE3) cells harboring pET30a/His-EDDIE-
AMP were induced by IPTG, and the expression of His-
EDDIE-AMP proteins was analyzed by SDS-PAGE (Fig-
ure 4). Fusion proteins of 20 kDa represented the major-
ity of the insoluble components in cell lysates. The
recombinant His-EDDIE-AMPs were estimated to con-
stitute about 40% of the total protein present in cells.
The yield of inclusion bodies was quite high due to the
properties of the fusion partner (high content of hydro-
phobic residues).
Refolding and activity analysis
Purified His-EDDIE-AMP inclusion bodies were diluted
in optimized refolding buffer and incubated to enable
self-cleavage to occur. To examine the antimicrobial
activity of six recombinant AMPs, the purified superna-
tants were assayed using a radial diffusion assay. As
Figure 2 Agarose gel electrophoresis of the PCR products of
the GFP gene and of plasmid pET30a/His-EDDIE-GFP. (A) Lane
M: molecular weight marker; Lane 1: plasmid of pET30a/His-EDDIE-
CAD; Lane 2: plasmid of pET30a; Lane 3-5: plasmid of pET30a/His-
EDDIE-GFP; (B) Lane M: molecular weight marker; Lane 1: PCR
products of linearized plasmid pET30a/His-EDDIE-GFP; Lane 2: PCR
products of GFP genes used pET30a/His-EDDIE-GFP as template.
Figure 3 Gel analysis of six recombinant pET30a/His-EDDIE-
AMP expression vectors. (A) Lane M: molecular weight markers;
Lane 1-4: PCR product of four recombinant expression vector pET-
His-EDDIE-AMPs; Lane 5: PCR product of vector pET-His-EDDIE-GFP;
(B) Lane M: molecular mass makers; Lane 1-2: PCR product of
Histatin6 and BLP-7 genes; (C) Lane M: molecular mass makers; Lane
1: plasmid of pET30a/His-EDDIE-GFP; Lane 2-7: plasmids of six
pET30a/His-EDDIE-AMPs;.
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AMPs, indicating that all six AMPs had specific bacteri-
cidal activities against E. coli ATCC2592, M. luteus or S.
cerevisiae. No inhibition zones were seen around the
negative control spots. The recombinant AMPs were
clearly bioactive and very effective in killing these sensi-
tive strains.
Discussion
We have described a new method for cloning and
expressing AMP genes. The desired AMPs are amplified
using ORF-specific primers with flanking sequences
identical to the two ends of a linearized vector. The
PCR product and the linearized vector are then cotrans-
formed into E. coli cells, where the ORF is incorporated
into the vector in vivo. Short AMPs can even directly
incorporate into the linearized vector through self-liga-
tion. Unlike conventional methods that use restriction
enzymes or site-specific recombinases, PCR products
could be seamlessly assembled without the need for spe-
cific sequences for ligation or site-specific recombination
[25]. This system is more efficient than cloning methods
requiring ligase [26,27] and will be useful for standard
DNA cloning and for constructing genome-scale clone
resources that facilitate functional analysis [23].
Most AMP genes are very small (100-200 bases) and it
is difficult to identify recombinant plasmids containing
these genes. We, therefore, incorporated the GFP repor-
ter gene into the expression vector to enable convenient
recombinant colony picking.
AMPs expressed as Npro fusions are deposited as
insoluble proteins in inclusion bodies. This greatly
increases yield due to resistance to proteolytic degrada-
tion. During refolding in vitro, EDDIE self-cleaved at the
specific site and the six target peptides were released.
Our construct also encodes the (His)6 affinity tag,
Figure 4 SDS-PAGE analysis of recombinant His-EDDIE-AMPs
expressed in E. coli BL21 (DE3). Lane M: the molecular weight
markers; Lane 1: crude cells extracts of uninduced E. coli BL21
containing pET-His-EDDIE-AMP; Lane 2: crude cells extracts after 5 h
past the induction with IPTG of E. coli BL21 containing pET-His-
EDDIE-AMP; The molecular weights of the new protein components
agree well with those predicted for the fusion proteins.
Figure 5 Detection of the antibacterial activities of candidate
antimicrobial peptides against E. coli and M. luteus. B: refolding
buffer; IB: Inclusion bodies of His-EDDIE-AMPs; a: antimicrobial
activities assay against S. cerevisiae; b: antimicrobial activities assay
against E. coli; c: antimicrobial activities assay against M. luteus; (A)
026, Hexapeptide; (B) 054, BLP-7; (C) 099, Temporin G; (D) 801,
human Histatin 6; (E) 726, Combi-1; (F) 803, human Histatin 9.
Table 1 Primers for vector construction
Primer
name
Sequence(5’-3’)
Pf GACACAGCGAACGGCGCAGCTGGTCACCCACAGCGGGCAAT
Pr GAGCTGTACAAGTGAAAGCTTGCGGCCGCACTCGAGCAC
Gf GCCGTTCGCTGTGTCGCACAAT
Gr TCACTTGTACAGCTCGTCCATGCCAT
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and straightforward purification using Ni
2+-chelating
affinity chromatography after refolding. The target pep-
tides could be easily purified to homogeneity.
These results validated this high throughput AMP
subcloning method. Using this method, we successfully
cloned 40 peptides into the expression vector and iden-
tified about 20 new AMPs from Brassica napus cDNA
libraries that showed antimicrobial activities (data not
shown). This approach, combined with bioinformatic
analyses of genome and EST sequence data, will be use-
ful in screening for new AMPs.
Conclusions
In conclusion, this is a simple, reliable, automated,
robust, flexible and low-cost expression cloning
approach in which PCR fragments are fused into an
expression vector without unwanted amino acids. This
strategy advances the methodologies available for AMP
prokaryote expression. The main barriers to AMP
expression, such as, codon preference, the intrinsic anti-
microbial activity of AMPs to host cells, and inefficient
production of AMPs owing to proteolytic degradation,
are overcome by this expression system.
Methods
Materials
E. coli XL-GOLD (Stratagene, USA) was used as the host
for subcloning and plasmid amplification. E. coli BL21
(DE3) was used as the host for expression of recombinant
protein. E. coli ATCC2592 and M. luteus ACCC11001
were used as indicators in the antimicrobial assay of the
six antimicrobial peptides. pET30a (Novagen, Madison,
WI, USA) was used as a vector construction and
Table 2 Antimicrobial peptides expressed in this research
AMP database
No.
Origin Amino acid sequences of mature peptide Length Anti characteristics
AP00054 Bombinin-like peptide 7, BLP-7 GIGGALLSAGKSALKGLAKGLAEHFAN 27 Gram + & Gram-
AP00099 Temporin G FFPVIGRILNGIL 13 Gram + & Gram-
AP00026 Hexapeptide, LfcinB6 RRWQWR 6 Gram + & Gram-, Virus, Fungi, Cancer cells
AP00726 Combi-1 RRWWRF 6 Gram + & Gram-, Fungi
AP00803 human Histatin 9 RKFHEKHHSHRGYR 14 Fungi
AP00801 human Histatin 6 DSHAKRHHGYKRKFHEKHHSHRGYR 25 Fungi
Table 3 Antimicrobial peptides expressed in this research
AMPs Name Oligomer sequence (5’-3’)
Hexapeptide 026 F TTAACGCCATTGCCAGCGACGGCAGCTGGTCACCCACAG
026R CGTCGCTGGCAATGGCGTTAAAAGCTTGCGGCCGC
Combi-1 726 F TTAGAAACGCCACCAACGACGGCAGCTGGTCACCCACAG
726R CGTCGTTGGTGGCGTTTCTAAAAGCTTGCGGCCGC
Temporin
G
099 F CAGAATGCGGCCAATGACCGGAAAAAAGCAGCTGGTCACCCACAG
099R ATTGGCCGCATTCTGAATGGCATCCTGTAAAAGCTTGCGGCCGC
human
Histatin 9
803 F TGGCTGTGGTGTTTCTCATGGAATTTACGGCAGCTGGTCACCCACAG
803R AGAAACACCACAGCCATCGTGGGTATCGTTAAAAGCTTGCGGCCGC
BLP-7 054-1 CTGTGGGTGACCAGCTGCGGCATTG
054-2 GGGCGCTTTTTCCCGCGCTCAGCAGCGCGCCTCCAATGCCGCAGCTGGTC
054-3 GCGGGAAAAAGCGCCCTGAAAGGCCTGGCGAAAGGCTTGGCGGAACATTT
054-4 GCGGCCGCAAGCTTTTAATTCGCAAAATGTTCCGCCAAGCCTT
human
Histatin 6
801-1 CTGTGGGTGACCAGCTGC
801-2 CTTATAGCCGTGATGACGCTTCGCATGGCTATCGCAGCTGGTCACCCACA
801-3 AAGCGTCATCACGGCTATAAGCGCAAGTTTCACGAAAAACACCACAGCCA
801-4 GCGGCCGCAAGCTTTTAACGATAACCACGATGGCTGTGGTGTTTTTCGT
backbone eF TGAGATCCGGCTGCTAACAAAGCCC
backbone eR GCAGCTGGTCACCCACAGCG
Ke et al. BMC Biotechnology 2012, 12:10
http://www.biomedcentral.com/1472-6750/12/10
Page 5 of 7recombinant protein expression plasmid. Restriction
enzymes NdeIa n dSalI were purchased from Takara
(Dalian, China).
Construction of the pET30a/His-EDDIE-GFP expression
vector
The plasmids containing the Npro mutant, EDDIE, were
constructed according to Zhang et al. [22]. To enable
green/white screening of recombinant clones (green
colonies indicate the presence of uncut parental vector),
the PCR primers Gf and Gr were designed according to
the reported DNA sequence of GFP (GenBank accession
no. ABN41558), with an added 18 bases flanking the
sequences complementary to the two ends of linearized
vector (Table 1). The pET30a/His-EDDIE-CAD vector
was amplified using primers Pf and Pr (25 cycles of 95°
C for 10 s, 65°C for 30 s, and 72°C for 6 min using Pyr-
obest DNA polymerase; Takara Bio Inc., Shiga, Japan),
and the linear PCR product, with 18 bases at each end
homologous to GFP, was digested by DpnI and purified.
The plasmid was then generated by the seamless
enzyme free cloning method [24], and was named
pET30a/His-EDDIE-GFP (Figure 1). 5 μLo fp u r i f i e d
PCR product (100-300 ng) and 1 μL( 5 0n g )o ft h e
appropriately linearized vector were mixed and trans-
formed into 50 μLo fE. coli XL-GOLD chemically com-
petent cells by heat shock and then plated on selection
plates (containing 50 μg/mL kanamycin). The recombi-
nant colonies were easily selected by visualizing GFP
fluorescence under ultraviolet light.
Construction of the AMP expression vector with EDDIE as
a fusion partner
Six AMPs were selected from the AMP database [28]
(Table 2). The AMP sequences were optimized accord-
ing to E. coli codon usage. For short AMPs, the sense
and antisense primers contained the reported DNA
sequence and 18 bases of overlap with each other. Their
3’ ends also contained the EDDIE C-terminal sequences
and the ends of MCS of the vector, respectively. For
longer AMPs, BLP-7 and Histatin 6, genes were
assembled using 4 primers in a one-step PCR reaction.
Vector was amplified with the PCR primers, backboneF
and backboneR, which were designed according to the
EDDIE C-terminal sequences and the ends of MCS of
the vector, respectively (Table 3). The pET30a/His-
EDDIE-GFP vector was amplified with the primers, and
the linearized vector was purified and digested with
DpnI. The PCR reaction was carried out for 25 cycles,
each cycle consisting of 30 s at 94°C, 30 s at 62°C, and 7
min at 72°C. The PCR products covalently join to vec-
tors with the corresponding ends in vivo when trans-
formed into E. coli. White colonies were picked, and
then sequenced to ensure that the coding sequence was
correct. The resulting plasmids were named pET30a/
His-EDDIE-AMPs, respectively (Figure 1B).
Expression and purification of fusion protein
The pET30a/His-EDDIE-AMP plasmids were trans-
formed into the expression host, E. coli BL21 (DE3)
(Novagen, Madison, WI, USA). One colony was used to
inoculate 50 mL LB (1% Bacto-tryptone, 0.5% yeast
extract, and 8 mM NaCl) medium supplemented with
50 μg/mL kanamycin, and grown overnight in a 37°C in
a shaking incubator. The fully grown culture was mixed
with 1 L LB medium with the same antibiotics the next
morning. The culture was grown at 25°C, and IPTG was
added to a final concentration of 1 mM when the
OD600 reached 0.5. The culture was harvested 5 h later
and the cells were washed and resuspended in 30 mL
PBS buffer (NaCl 137 mM, KCl 2.7 mM, Na2HPO4 4.3
mM, KH2PO4 1.4 mM, pH 7.2-7.4). The cells were lysed
by freeze-thaw and the DNA was fragmented by ultraso-
nication. The insoluble inclusion bodies were isolated by
14,000 × g centrifugation for 30 min in 4°C. The pellet
was washed three times with washing buffer (10 mM
Tris/HCl, pH 7.6; 200 mM NaCl, 2 mM 2-mercap-
toethanol, and 1% Triton X-100) and then solubilized in
denaturing buffer (8 M urea; 20 mM Tris-HCl, pH 7.6;
and 5 mM 2-mercaptoethanol).
Refolding and activity analysis
Purified His-EDDIE-AMPs inclusion bodies were
refolded by rapid 1:50 dilution in optimized refolding
buffer (500 mM NaCl, 20 mM Tris, 2 mM EDTA, 5%
glycerol, 10 mM DTT, 0.01% Tween-20, pH 7.5) and
incubated at an appropriate temperature without stir-
ring. During refolding, EDDIE restored its correct con-
formation and self-cleaved at the specific site, releasing
AMPs from the fusion bodies. Renatured protein solu-
tion was then clarified by 15,000 × g centrifugation for
30 min in 4°C. Then the insoluble sample was removed
by filtering through 0.45 μm membrane and AMPs were
left in the supernatant. The supernatants were applied
to a Ni-NTA His-bind column for purification.
Standard SDS-PAGE (12% gel) was applied to assay
fusion proteins. Band density was analyzed using a GEL-
DOC 2000 gel documentation system (BIO-Rad, Hemel
Hempstead, UK) and Quantity One software, version
4.4.0 was used to determine the fraction of target pro-
tein. EDDIE protein was quantified using a BCA protein
assay kit (Pierce, Rockford, IL, USA). Antimicrobial
activity of recombinant AMPs was detected using a
radial diffusion assay [29]. Briefly, E. coli ATCC2592, M.
luteus ACCC11001 and S. cerevisiae were grown to the
mid-logarithmic phase and washed. Approximately 2 ×
10
6 cfu/mL bacteria were incorporated into a thin (1.2
mm) agarose underlay gel that contained 1% (wt/vol)
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the solidified agarose and these were filled with 100 μL
of AMP sample. After the plates were incubated for 12
h at 37°C, the diameter of the clear zone surrounding
each well was measured to evaluate the antimicrobial
activity. Refolding buffer and inclusion bodies were used
as negative controls. The above assays were performed
in triplicate.
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